// IP Marketing video - START// IP Marketing video - END

U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
In particular, the three companies will cooperate to boost investments in biotechnology and clinical research in Armenia
Baddiel and Herring travelled to the Armenian capital of Yerevan for the opening episode of the Brewster's Millions-inspired show.
Authored by entrepreneurs Maxim Sychev and Seyran Harutyunyan, Armenia's first-of-its-kind bobsleigh runway will open on July 1, 2018.
Smithsonian Magazine has prepared an article about the Caucasian leopard which dates back millennia in Armenia’s history and iconography.
Partner news